Suzuken Co., Ltd. (SZUKF)

USD 30.3

(0.0%)

Operating Income Summary of Suzuken Co., Ltd.

  • Suzuken Co., Ltd.'s latest annual operating income in 2024 was 230.42 Million USD , up 6.96% from previous year.
  • Suzuken Co., Ltd.'s latest quarterly operating income in 2024 FY was 230.42 Million USD , down -6.11% from previous quarter.
  • Suzuken Co., Ltd. reported an annual operating income of 245.42 Million USD in 2023, up 48.51% from previous year.
  • Suzuken Co., Ltd. reported an annual operating income of 165.25 Million USD in 2022, up 99.39% from previous year.
  • Suzuken Co., Ltd. reported a quarterly operating income of 230.42 Million USD for 2024 FY, down -6.11% from previous quarter.
  • Suzuken Co., Ltd. reported a quarterly operating income of 70.54 Million USD for 2024 Q3, down -20.44% from previous quarter.

Annual Operating Income Chart of Suzuken Co., Ltd. (2024 - 2016)

Historical Annual Operating Income of Suzuken Co., Ltd. (2024 - 2016)

Year Operating Income Operating Income Growth
2024 230.42 Million USD 6.96%
2023 245.42 Million USD 48.51%
2022 165.25 Million USD 99.39%
2021 82.87 Million USD -72.53%
2020 301.71 Million USD 22.65%
2019 246 Million USD 32.56%
2018 185.58 Million USD 10.52%
2017 167.92 Million USD -33.18%
2016 251.29 Million USD 0.0%

Peer Operating Income Comparison of Suzuken Co., Ltd.

Name Operating Income Operating Income Difference
China Medicine Corporation 12.26 Million USD -1778.528%
DH Enchantment Inc. -145.23 Thousand USD 158752.794%
Exlites Holdings International, Inc. -15.49 Thousand USD 1487677.353%
Itonis, Inc. -38.31 Thousand USD 601576.721%
One Step Vending Corp. -27.79 Thousand USD 829267.801%
MediPal Holdings Corporation 312.71 Million USD 26.315%
PD-Rx Pharmaceuticals, Inc. -190.47 Thousand USD 121072.995%
Pharmagen, Inc. -2159.03 USD 10672750.774%